Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268046 · ClinicalTrials.gov registry record · Phase 1
Aging and Estrogen on Cortical Function
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01268046: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT01268046 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01268046, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will focus on how estrogen affects parts of the brain associated with memory and how the effect of estrogen is altered with aging in postmenopausal women.
Interventions
- DRUG Estradiol oral capsule
- DRUG transderman estrogen patch
- DRUG trasdermal placebo patch
- DRUG placebo oral capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-11 |
| Est. Completion | 2013-12-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01268046
The ClinicalTrials.gov registry entry for NCT01268046 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Estradiol oral capsule is the first listed.
NCT01268046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01268046 about?
NCT01268046 is a clinical study titled "Aging and Estrogen on Cortical Function". This study will focus on how estrogen affects parts of the brain associated with memory and how the effect of estrogen is altered with aging in postmenopausal women.
What is the current status of trial NCT01268046?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2009-11. Estimated completion is 2013-12-02.
What interventions are being tested in trial NCT01268046?
The interventions under investigation include: Estradiol oral capsule (DRUG), transderman estrogen patch (DRUG), trasdermal placebo patch (DRUG), placebo oral capsule (DRUG).
Who is sponsoring clinical trial NCT01268046?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.